SCHEMBL29253705

SCHEMBL29253705

C[C@@H](OC(N)=O)C(=O)NCc1ccccc1F

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC1A2 P43004 1/20 0.54
▸ RIPK1 Q13546 1/20 0.48
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ SCN9A Q15858 1/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MAPT P10636 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ PKM P14618 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29253680 1.00 SLC1A2 (0.54) SLC1A2RIPK1KMT2APOLBALDH1A1
SCHEMBL29253682 1.00 SLC1A2 (0.54) SLC1A2RIPK1KMT2APOLBALDH1A1
SCHEMBL2905073 0.82 SLC1A2 (0.65) SLC1A2RIPK1ALDH1A1HPGDMAPT
SCHEMBL29253671 0.82 RIPK1 (0.50) SLC1A2RIPK1KMT2APOLBALDH1A1
SCHEMBL29253769 0.82 RIPK1 (0.50) SLC1A2RIPK1KMT2APOLBALDH1A1
SCHEMBL25209028 0.81 SLC1A2 (0.60) SLC1A2RIPK1ALDH1A1HPGDMAPT
SCHEMBL25259336 0.81 SLC1A2 (0.60) SLC1A2RIPK1ALDH1A1HPGDMAPT
SCHEMBL25242066 0.81 SLC1A2 (0.60) SLC1A2RIPK1ALDH1A1HPGDMAPT
SCHEMBL29253678 0.80 KMT2A (0.61) SLC1A2KMT2AALDH1A1SCN9AHPGD
SCHEMBL29253655 0.80 KMT2A (0.61) SLC1A2KMT2AALDH1A1SCN9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118302410-A Deuterated functionalized derivatives of alpha-alanine, in particular for the treatment of neurological diseases 雅盖隆大学 2024-07-05 — — CN disclosed
Send feedback